# Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. – FDA Inspection, May 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/guangdong-zhanjiang-jimin-pharmaceutical-co-ltd/7a8796ce-a629-48ac-8762-e65e88ba439a
Source feed: FDA_Inspections

> FDA inspection 1014454 of Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd., May 19, 2017. Classification: Official Action Indicated (OAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014454
- Company Name: Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
- Inspection Date: 2017-05-19
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/andrew-j-idzior/5b639c02-d062-4a5a-aa4a-8362ddfba2b6)

Company: https://www.keypedia.com/companies/guangdong-zhanjiang-jimin-pharmaceutical-co-ltd/0f0aef27-7fb5-4f54-85ff-75163c67616d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
